Wassim Kassouf

Biography

After medical school and residency at McGill University, Dr Wassim Kassouf completed a urologic oncology fellowship at M. D. Anderson Cancer Center in Houston, Texas. He then arrived on faculty in August 2006 at the McGill University Health Center, Montreal, Canada.  He is a Professor in the Division of Urology and Vice-Chair, academic affairs, of the Department of Surgery at McGill University. Dr. Kassouf’s clinical practice focuses on bladder, prostate, and renal cancer. He has led several national guidelines for optimizing quality of care in urologic cancer management and has published over 270 peer-review manuscripts and book chapters. He is the founder of the national Canadian Bladder Cancer Network, a co-founder of Bladder Cancer Canada (BCC), co-chair of the National Cancer Institute of Canada’s disease-oriented group in bladder cancer, and an executive member of the NIH Genitourinary steering committee Bladder Cancer Task Force. He has served as program director over the last 6 years and currently is a member of the Royal College Urology Examination board committee.  Dr Kassouf is a graduate of the AUA Leadership Program and received several awards including the American Urological Association Young Urologist of the Year, AUA Research Scholar Award, Canadian Urological Association Scholarship Award, FRSQ Clinician Scientist Research Scholar Award, and the Everett C. Reid Teaching Excellence Award. 

Research Interest

His clinical and translational research focuses on the biology and therapy of bladder cancer.  His translational research over the recent years have been primarily on biomarkers and radiosensitization in bladder cancer.  Phase I clinical trial of everolimus combined with trimodality therapy in patients with invasive bladder cancer Bachir B, Souhami L, Mansure JJ, Brimo F, Vanhuyse M, Sturgeon J, Cury F, Aprikian A, Tanguay S, and Kassouf W (Bladder Cancer, in press)